D M Musher

Summary

Country: USA

Publications

  1. pmc Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis
    Daniel M Musher
    Medical Care Line Infectious Disease Section, Micheal E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Clin Microbiol 44:2304-6. 2006
  2. ncbi request reprint Association of hypercoagulable states and increased platelet adhesion and aggregation with bacterial colonization of intravenous catheters
    Daniel Musher
    Medical Service, Veterans Affairs Medical Center, and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
    J Infect Dis 186:769-73. 2002
  3. doi request reprint Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study
    Daniel M Musher
    Infectious Disease Section, The Medical Care Line, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Clin Infect Dis 48:e41-6. 2009
  4. ncbi request reprint The association between pneumococcal pneumonia and acute cardiac events
    Daniel M Musher
    Medical Care Line, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 45:158-65. 2007
  5. pmc Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay
    Daniel M Musher
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    J Clin Microbiol 45:2737-9. 2007
  6. ncbi request reprint Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia
    Daniel M Musher
    Infectious Disease Section, Medical Service, Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Infect Dis 39:165-9. 2004
  7. ncbi request reprint Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide
    Daniel M Musher
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Antimicrob Chemother 59:705-10. 2007
  8. ncbi request reprint Contagious acute gastrointestinal infections
    Daniel M Musher
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, and the Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    N Engl J Med 351:2417-27. 2004
  9. ncbi request reprint Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia
    Daniel M Musher
    Infectious Disease Section, Medical Service, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 43:1004-8. 2006
  10. ncbi request reprint Nitazoxanide for the treatment of Clostridium difficile colitis
    Daniel M Musher
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Clin Infect Dis 43:421-7. 2006

Collaborators

Detail Information

Publications64

  1. pmc Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis
    Daniel M Musher
    Medical Care Line Infectious Disease Section, Micheal E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Clin Microbiol 44:2304-6. 2006
    ..influenzae, biotype III. Infection progressed despite the presence of adequate serum bactericidal antibody, probably due to the absence of complement in ascites fluid...
  2. ncbi request reprint Association of hypercoagulable states and increased platelet adhesion and aggregation with bacterial colonization of intravenous catheters
    Daniel Musher
    Medical Service, Veterans Affairs Medical Center, and Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
    J Infect Dis 186:769-73. 2002
    ....
  3. doi request reprint Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study
    Daniel M Musher
    Infectious Disease Section, The Medical Care Line, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Clin Infect Dis 48:e41-6. 2009
    ..We report a prospective, double-blind, randomized controlled trial comparing nitazoxanide with vancomycin for treatment of CDI...
  4. ncbi request reprint The association between pneumococcal pneumonia and acute cardiac events
    Daniel M Musher
    Medical Care Line, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 45:158-65. 2007
    ..We sought to determine the incidence of such events in patients who were hospitalized for community-acquired pneumococcal pneumonia...
  5. pmc Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay
    Daniel M Musher
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    J Clin Microbiol 45:2737-9. 2007
    ....
  6. ncbi request reprint Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia
    Daniel M Musher
    Infectious Disease Section, Medical Service, Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Infect Dis 39:165-9. 2004
    ..05). Microscopic examination of sputum samples before antibiotics were administered and performance of culture within 24 h of receipt of such treatment yielded the correct diagnosis in >80% of cases of pneumococcal pneumonia...
  7. ncbi request reprint Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide
    Daniel M Musher
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Antimicrob Chemother 59:705-10. 2007
    ..We have recently shown that nitazoxanide is as effective as metronidazole in initial therapy for C. difficile colitis. We hypothesized that this drug might be effective in treating patients who fail therapy with metronidazole...
  8. ncbi request reprint Contagious acute gastrointestinal infections
    Daniel M Musher
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, and the Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    N Engl J Med 351:2417-27. 2004
  9. ncbi request reprint Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia
    Daniel M Musher
    Infectious Disease Section, Medical Service, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 43:1004-8. 2006
    ..Despite the widespread acceptance of the 23-valent pneumococcal capsular polysaccharide vaccine (PPV), its protective effect continues to be disputed. We describe a novel approach to examine the protective effect of this vaccine...
  10. ncbi request reprint Nitazoxanide for the treatment of Clostridium difficile colitis
    Daniel M Musher
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Clin Infect Dis 43:421-7. 2006
    ..Nitazoxanide, a nitrothiazolide, blocks anaerobic metabolism of eukaryocyes and effectively treats intestinal infestation due to Cryptosporidium or Giardia species. At low concentrations, this compound inhibits C. difficile in vitro...
  11. ncbi request reprint Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine
    Daniel M Musher
    Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, and Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    J Infect Dis 191:1063-7. 2005
    ..Recurrent pneumococcal bacteremia in patients who have undergone splenectomy may indicate a genetically regulated failure to respond to PPV-23; PCPV-7 may stimulate production of IgG to PSs in such patients...
  12. ncbi request reprint Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole
    Daniel M Musher
    Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 40:1586-90. 2005
    ..In recent years, the rate of response to treatment with this drug has appeared to be much lower...
  13. doi request reprint Treatment of clostridium difficile colitis in the critical care setting
    Daniel M Musher
    Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030, USA
    Crit Care Clin 24:279-91, viii. 2008
    ..This article emphasizes treatment of Clostridium difficile colitis, considers diagnostic techniques, and describes means for preventing the spread of this infection in the intensive care setting...
  14. ncbi request reprint Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile
    Anna Wanahita
    Infectious Disease Section, Medical Service, Veterans Affairs Medical Center, Houston, TX, 77030, USA
    Clin Infect Dis 34:1585-92. 2002
    ..C. difficile infection is a prominent cause of leukocytosis and this diagnosis should be considered for patients with WBC counts of >/=15,000 cells/mm(3), even in the absence of diarrheal symptoms...
  15. ncbi request reprint Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia
    D M Musher
    Medical Service, Infectious Disease Section, Houston Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 32:534-8. 2001
    ..Detection of IgG antibody to PLY in precipitated CICs is not a reliable method for diagnosing pneumococcal pneumonia...
  16. ncbi request reprint Protection against bacteremic pneumococcal infection by antibody to pneumolysin
    D M Musher
    Medical Service, Infectious Disease Section, Houston Department of Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Infect Dis 183:827-30. 2001
    ..One hypothesis that might explain the study results is that, early in infection, IgG to pneumolysin blocks these effects in the alveoli, thereby protecting the host against bacteremic pneumococcal disease...
  17. ncbi request reprint A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics
    D M Musher
    Department of Medicine, Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030, USA
    Arch Intern Med 161:2538-44. 2001
    ..This article examines definitions of susceptibility and resistance of pneumococci, highlighting areas that have led to confusion and proposing a new way of understanding them...
  18. ncbi request reprint Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia
    D M Musher
    VA Medical Center, Houston, TX 77030, USA
    J Infect Dis 182:158-67. 2000
    ..Future vaccine studies may need to examine the functional capacity of antibodies as a surrogate for infection, in addition to measuring their concentration in serum...
  19. pmc Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia
    Daniel M Musher
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    J Infect Dis 198:1019-27. 2008
    ..We studied PPV, protein-conjugate pneumococcal vaccine (PCV), and immunologic "priming" with PCV followed by "boosting" with PPV in adults who had recovered from pneumococcal pneumonia...
  20. doi request reprint Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes
    Vicente F Corrales-Medina
    Department of Medicine, Baylor College of Medicine, Houston, Texas, USA vfmedina bcm edu
    Medicine (Baltimore) 88:154-9. 2009
    ..6; 95% CI, 24.5-92.5). The characteristics and strength of these associations suggest a causal role for the acute infection in this relationship...
  21. ncbi request reprint Treatment of Clostridium difficile-associated disease: old therapies and new strategies
    Saima Aslam
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Lancet Infect Dis 5:549-57. 2005
    ..Hospital infection control and pertinent use of antibiotics can limit the spread of CDAD. A vaccine directed against C difficile toxin may eventually offer a solution to the CDAD problem...
  22. ncbi request reprint Clostridium difficile lacks detectable superantigen activity
    Anna Wanahita
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA
    FEMS Immunol Med Microbiol 47:275-7. 2006
    ..Elevated white blood cell counts in C. difficile colitis are probably due to increased generation of cytokines such as interleukin-6 (IL-6) or IL-8...
  23. ncbi request reprint Clostridium difficile infection in patients with unexplained leukocytosis
    Anna Wanahita
    Medical Service, Infectious Disease Section, Veterans Affairs Medical Center, Houston, Texas 77030, USA
    Am J Med 115:543-6. 2003
    ..To determine whether unrecognized Clostridium difficile infection is responsible for a substantial proportion of cases of unexplained leukocytosis in a tertiary care hospital setting...
  24. ncbi request reprint Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus
    M E Dowell
    Infectious Disease Section, Veterans Affairs Medical Center, Houston, Texas 77030
    Am J Med 93:481-8. 1992
    ..Studies comparing ceftriaxone with 10 to 14 doses of procaine penicillin are needed to determine the most cost-effective treatment for asymptomatic neurosyphilis or presumed latent syphilis in this group of patients...
  25. doi request reprint The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century
    Adriana M Rueda
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Medicine (Baltimore) 89:331-6. 2010
    ..The overall mortality at 30 days was 16% and was similar in vaccinated and nonvaccinated subjects. IPD causes a wide spectrum of disease. Mortality is substantial. PPV23 is clearly not fully protective...
  26. doi request reprint Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
    Daniel M Musher
    Michael E DeBakey VA Medical Center, Houston, Texas, USA
    J Infect Dis 201:516-24. 2010
    ..This study assessed antibody levels for 5 years after primary vaccination or revaccination with 23-valent pneumococcal polysaccharide vaccine (PN23)...
  27. doi request reprint Hyperglycemia in diabetics and non-diabetics: effect on the risk for and severity of pneumococcal pneumonia
    Adriana M Rueda
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Infect 60:99-105. 2010
    ....
  28. pmc V(H)3 antibody response to immunization with pneumococcal polysaccharide vaccine in middle-aged and elderly persons
    Jose A Serpa
    Department of Medicine, Infectious Diseases Section, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Vaccine Immunol 18:362-6. 2011
    ..Age or repeated immunization does not appear to affect the V(H)3-idiotypic immunogenicity of PPV among middle-aged and elderly adults...
  29. ncbi request reprint Clostridium difficile: recent epidemiologic findings and advances in therapy
    Nicole L McMaster-Baxter
    Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Pharmacotherapy 27:1029-39. 2007
    ..Rifaximin and PAR-101 are under investigation. Other therapies, including polymers that bind C. difficile toxin and monoclonal antibodies to toxins, and preventive measures such as toxoid vaccines are also under study...
  30. ncbi request reprint Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis
    Richard M Cadle
    Michael E DeBakey Veterans Affairs Medical Center MEDVAMC, Houston, TX 77030, USA
    Am J Health Syst Pharm 64:2359-63. 2007
    ..difficile colitis, and recurrence of the disease in the 90 days after symptoms resolved. Outcomes of therapy were classified as cures, treatment failures, or disease recurrences...
  31. ncbi request reprint Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine
    Maria C Rodriguez-Barradas
    Baylor College of Medicine, Houston, Texas, USA
    Clin Infect Dis 37:438-47. 2003
    ..The immunogenicity of PV among patients receiving long-term HAART is modest. It seems best to immunize HIV-infected patients early in the course of disease...
  32. ncbi request reprint Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study
    Feng Yee Chang
    VA Medical Center, Infectious Disease Section, University Drive C, Pittsburgh, PA 15240, USA
    Medicine (Baltimore) 82:333-9. 2003
    ..Duration of antistaphylococcal therapy was not associated with relapse, but type of antibiotic therapy was. Nafcillin was superior to vancomycin in efficacy in patients with MSSA bacteremia...
  33. pmc In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis
    B A Perkins
    Section of Infectious Diseases, Medical Service, Department of Veterans Affairs Medical Center, Houston, Texas
    Antimicrob Agents Chemother 36:1785-7. 1992
    ..All isolates were inhibited by clinically achievable concentrations of trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, chloramphenicol, ciprofloxacin, cephalexin, cefuroxime, and cefpodoxime...
  34. ncbi request reprint Cutaneous manifestations of bacterial sepsis
    D M Musher
    Baylor College of Medicine, Houston
    Hosp Pract (Off Ed) 24:71-5, 80-2, 92 passim. 1989
    ..As noted, the pathogenetic significance of thrombosis observed in the lesions of DIC remains unclear.(ABSTRACT TRUNCATED AT 400 WORDS)..
  35. ncbi request reprint Identification, cloning, and sequencing of DNA essential for encapsulation of Streptococcus pneumoniae
    D A Watson
    Department of Biology, University of Houston, TX 77030, USA
    Curr Microbiol 31:251-9. 1995
    ..These results indicate that this region of the chromosome is highly conserved and, taken together with other independently derived data, suggest that interruptions or deletions within this DNA lead to unencapsulation...
  36. pmc Antibiotic susceptibilities of genetically characterized Streptococcus milleri group strains
    M Tracy
    Medical and Laboratory Services, Veterans Affairs Medical Center, Houston, Texas, USA
    Antimicrob Agents Chemother 45:1511-4. 2001
    ..Relatively small differences in antibiotic susceptibilities among species of the S. milleri group show that speciation is unlikely to be important in selecting an antibiotic to treat infection caused by one of these isolates...
  37. ncbi request reprint Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin
    N H Smith
    Infectious Disease Section, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, 561E, Houston, Texas 77030, USA
    Int J STD AIDS 15:328-32. 2004
    ....
  38. ncbi request reprint How contagious are common respiratory tract infections?
    Daniel M Musher
    Medical Service, Infectious Disease Section, Veterans Affairs Medical Center, and the Department of Medicine, Baylor College of Medicine, Houston, USA
    N Engl J Med 348:1256-66. 2003
  39. ncbi request reprint Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus
    Anjum S Kaka
    Section of Infectious Diseases, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX 77030, USA
    J Antimicrob Chemother 58:680-3. 2006
    ....
  40. doi request reprint The association between Staphylococcus aureus bacteremia and acute myocardial infarction
    Vicente F Corrales-Medina
    Michael E DeBakey VA Medical Center, Houston, Texas 77030, USA
    Scand J Infect Dis 41:511-4. 2009
    ..SAB increased the risk for MI 35-fold in the 2 d after recognition of this infection (IRR = 35.3; CI 16.7-74.7)...
  41. pmc In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations
    Samuel A Shelburne
    Section of Infectious Diseases 111G, Michael E DeBakey Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, TX 77030 4211, USA
    Antimicrob Agents Chemother 48:4016-9. 2004
    ..Community-associated MRSA were more likely to be synergistically inhibited by combinations of vancomycin and gentamicin versus vancomycin alone compared to inhibition associated with hospital-acquired strains...
  42. ncbi request reprint Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection
    Blanca E Gonzalez
    Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA
    Infect Control Hosp Epidemiol 27:1051-6. 2006
    ..This study examines the hypothesis that community-associated MRSA (CA-MRSA) strains now cause serious infections in hospitalized patients...
  43. ncbi request reprint Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus ("Streptococcus milleri group") are of different clinical importance and are not equally associated with abscess
    J E Claridge
    Department of Pathology, Baylor College of Medicine, and Veterans Affairs Medical Center, Houston, TX 77030, USA
    Clin Infect Dis 32:1511-5. 2001
    ..Our findings suggest that speciation of the SMG may guide diagnostic evaluation, give insight into the possible role of coinfecting organisms, and help assess the need to search for occult abscess...
  44. doi request reprint Clinical and microbiological end points in the treatment of pneumonia
    Daniel M Musher
    Medical Service, Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
    Clin Infect Dis 47:S207-9. 2008
    ..This brief contribution outlines areas for further consideration as new drugs are evaluated...
  45. pmc A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection
    Hoonmo L Koo
    Baylor College of Medicine, University of Texas Houston School of Public Health, Houston, Texas, USA
    Clin Infect Dis 48:e75-7. 2009
    ..We describe here the unique challenges of the identification of NoVs as the true etiologic pathogen in an outbreak occurring in a health care setting, where C. difficile infection is endemic, as well as the important lessons learned...
  46. doi request reprint Outcomes of treatment for hematogenous Staphylococcus aureus vertebral osteomyelitis in the MRSA ERA
    Daniel J Livorsi
    Section of Infectious Diseases, Baylor College of Medicine, One Baylor Plaza, BCM 286, N1319, Houston, TX 77030, USA
    J Infect 57:128-31. 2008
    ..aureus (MRSA) has complicated the treatment of this infection. Our objective was to evaluate therapeutic outcomes for S. aureus vertebral osteomyelitis in a setting of high MRSA prevalence...
  47. ncbi request reprint Computerized tomography (CT)-guided aspiration of abscesses: outcome of therapy at a tertiary care hospital
    Vaibhav Mehendiratta
    Department of Medicine Infectious Diseases Section, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX 77030, USA
    J Infect 54:122-8. 2007
    ..To review the experience with percutaneous aspiration of abscesses at a general, tertiary care hospital from 2000 to 2005...
  48. doi request reprint Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis
    Hoonmo L Koo
    Department of Medicine, Division of Infectious Diseases, Baylor College of Medicine, Houston, TX 77030, USA
    Clin Infect Dis 48:598-605. 2009
    ..Further study of the role of antimotility agents in providing symptomatic relief and reducing environmental contamination with infectious stool may be warranted...
  49. ncbi request reprint A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance
    Feng Yee Chang
    VA Medical Center, Infectious Disease Section, University Drive C, Pittsburgh, PA 15240, USA
    Medicine (Baltimore) 82:322-32. 2003
    ..MRSA as the infecting organism should be added to the list of risk factors for consideration of valvular resection in cases of endocarditis...
  50. ncbi request reprint An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease
    Saima Aslam
    Medical Service Infectious Disease Section, Michael E DeBakey Veterans Affairs Medical Center, Room 4B 370, 2002 Holcombe Boulevard, Houston, TX 77030, USA
    Gastroenterol Clin North Am 35:315-35. 2006
    ..Biotherapy and vaccination are currently being explored as treatment options for patients who have recurrent disease. Greater attention should be paid to hospital infection control policies and restriction of broad-spectrum antibiotics...
  51. ncbi request reprint Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent
    Saima Aslam
    Michael E DeBakey VA Medical Center, Section of Infectious Diseases, Room 4B 370, 2002 Holcombe Blvd, Houston, TX 77030, USA
    Future Microbiol 2:583-90. 2007
    ..Further investigations regarding its use in patients with AIDS is needed. Nitazoxanide represents a significant advance in the treatment of intestinal parasitic infections worldwide...
  52. doi request reprint Multiple-dose granulocyte-macrophage-colony-stimulating factor plus 23-valent polysaccharide pneumococcal vaccine in patients with chronic lymphocytic leukemia: a prospective, randomized trial of safety and immunogenicity
    Amar Safdar
    Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 113:383-7. 2008
    ....
  53. ncbi request reprint Interaction between human polymorphonuclear leukocytes and Streptococcus milleri group bacteria
    Anna Wanahita
    Medical Service, Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX 77030, USA
    J Infect Dis 185:85-90. 2002
    ..This study helps explain the capacity of SMG to cause abscesses. It is unclear, however, why viridans streptococci, bacteria that rarely produce abscesses, share some of these same properties...
  54. ncbi request reprint A 57-year-old man with a fluid-containing lung cavity: infection of an emphysematous bulla with methicillin-resistant Staphylococcus aureus
    Divay Chandra
    Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Chest 130:1942-6. 2006
  55. ncbi request reprint Epidemic Clostridium difficile
    Daniel M Musher
    N Engl J Med 354:1199-203; author reply 1199-203. 2006
  56. ncbi request reprint The usefulness of sputum gram stain and culture
    Daniel M Musher
    Arch Intern Med 165:470-1. 2005
  57. ncbi request reprint Pneumococcal vaccine--direct and indirect ("herd") effects
    Daniel M Musher
    N Engl J Med 354:1522-4. 2006
  58. ncbi request reprint Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
    Lionel A Mandell
    McMaster University Medical School, Hamilton, Ontario, Canada
    Clin Infect Dis 44:S27-72. 2007
  59. ncbi request reprint Emergence of macrolide resistance during treatment of pneumococcal pneumonia
    Daniel M Musher
    N Engl J Med 346:630-1. 2002
  60. ncbi request reprint Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults
    Lionel A Mandell
    McMaster University, Hamilton, Ontario, Canada
    Clin Infect Dis 37:1405-33. 2003
  61. ncbi request reprint The lack of therapeutic benefit of adding hydroxyurea to highly active antiretroviral therapy (HAART)
    Omar Y Gonzalez
    J Acquir Immune Defic Syndr 30:363-4. 2002
  62. ncbi request reprint The long-term outcome of treatment of Clostridium difficile colitis
    Daniel M Musher
    Clin Infect Dis 45:523-4. 2007
  63. ncbi request reprint Anemia and infection
    Daniel M Musher
    Clin Infect Dis 39:1731-2; author reply 1732. 2004
  64. ncbi request reprint Pneumococcal serotypes and virulence
    Daniel M Musher
    J Infect Dis 193:477; author reply 477-8. 2006